CD274 and neoplasm: ICIs include programmed cell death receptor (PD1) and programmed cell death ligand‐1 (PD‐L1), mainly by overcoming tumor cell‐mediated immune dysfunction, destroying immune tolerance, enhancing or restoring a patient's own antitumor immunity to kill tumor cells.